KWR

Quaker Chemical Corp. (KWR) - 10-Q Summary for Period Ended June 30, 2025

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2025. Quaker Chemical Corporation (doing business as Quaker Houghton) is the global leader in industrial process fluids, operating in over 25 countries across three reportable segments: Americas, Europe/Middle East/Africa (EMEA), and Asia/Pacific. The company serves steel, aluminum, automotive, aerospace, and metalworking industries.

Key Financial Metrics

Material Changes vs. Prior Period

• Significant Impairment Charge: The company recorded a non-cash goodwill impairment charge of $88.8 million in Q2 2025 related to the EMEA reporting unit. This was driven by lower-than-projected financial performance due to soft end-market conditions and an increased cost of capital stemming from tariff uncertainty.
• Revenue Growth: Q2 net sales increased 4% year-over-year, driven by a 6% contribution from acquisitions and a 2% volume increase, partially offset by a 4% decline in selling price and product mix.
• Acquisitions: The company completed the acquisition of Dipsol Chemicals Co., Ltd. (Japan) for a net purchase price of approximately $155.5 million in April 2025. Smaller acquisitions of Natech (UK) and CSI (South Africa) were also completed in Q2.
• Restructuring: Restructuring and related charges increased significantly to $8.8 million in Q2 2025 (vs. $0.3 million in Q2 2024) as part of a global cost optimization program targeting 380 headcount reductions.
• Debt Levels: Total debt increased to $936.7 million from $708.3 million at year-end 2024, primarily due to borrowings used to fund the Dipsol acquisition.

Guidance, Outlook, and Risks

• Outlook: Management notes a continuation of soft end-market conditions and heightened uncertainty regarding global trade and tariffs, particularly impacting the Americas and EMEA segments. The Asia/Pacific segment continues to show growth.
• Restructuring Progress: The global cost and optimization program is expected to be substantially complete by the end of 2025, with additional actions approved in H1 2025 expected to generate at least $35.0 million in annualized cost savings.
• Tax Legislation: The "One Big Beautiful Bill Act" (H.R. 1) was signed into law on July 4, 2025. The company is evaluating its impact on deferred tax balances and international operations, noting it may affect future tax assets and liabilities.
• Risks: Key risks include the impact of tariffs and trade restrictions, inflationary pressures on raw material costs, foreign currency fluctuations, and potential economic downturns affecting customer demand.

Investor Verification Checklist

• EMEA Goodwill Impairment: Verify the assumptions used in the fair value assessment of the EMEA reporting unit, specifically regarding the weighted average cost of capital (WACC) and projected EBITDA under current tariff scenarios.
• Acquisition Integration: Monitor the integration progress and synergy realization of the Dipsol acquisition, which contributed significantly to Q2 sales but also added to SG&A and inventory step-up amortization costs.
• Restructuring Cash Outflows: Track actual cash payments for restructuring against the projected $15.9 million paid in H1 2025 to ensure alignment with the total one-time cash cost estimates.
• Tax Rate Volatility: Review the impact of the new H.R. 1 tax legislation on the company's effective tax rate in future periods, as the current rate was heavily influenced by the non-deductible impairment charge.
• Debt Covenants: Confirm continued compliance with the Credit Facility covenants (consolidated interest coverage and net leverage ratios) given the increased debt load from recent acquisitions.